$11.82
0.776.97%
À la fermeture: -
$11.89
0.070.59%
Après les heures de négociation: Oct 31, 7:51 PM EDT
Comments
Loading...
Activité de trading des initiés
Suivez les dernières activités de délit d'initié Avantor. Restez informé des achats, des ventes et de l'impact sur le marché des actions Avantor.
Qu’est-ce que l’activité d’initié ?
L'activité de délit d'initié implique des initiés de l'entreprise, tels que des dirigeants, des administrateurs et des employés, qui s'engagent dans des transactions sur les actions de leur propre entreprise. Les transactions d'achat et de vente des initiés fournissent des informations précieuses sur leur confiance dans les performances futures de l'entreprise.
Que font les Avantor Inc Insiders ?
À Avantor Inc, une récente activité d’initiés a attiré l’attention. Au cours des 30 derniers jours, les initiés n'ont signalé aucune vente au cours des 30 derniers jours, tandis que les initiés ont déclaré avoir acheté un total de 100.00K actions pour une valeur totale de $1.13M.
Achats et ventes récents notables d’initiés
- Le août 22, 2025 Greg Summe, le DIRECTOR purchased 100K actions pour $12.56 chacune.
- Le octobre 31, 2025 Greg Summe, le DIRECTOR purchased 100K actions pour $11.25 chacune.
- Le août 6, 2025 Steven Eck, le SVP & CHIEF ACCOUNTING OFFICER sold 3.48K actions pour $11.39 chacune.
Statistiques de propriété pour Avantor Inc
Actions en circulation
681.815M
Actions détenues par les initiés
5.864M
Pourcentage d'actions détenu par les initiés
0.86%
Actions détenues par les institutions
517.532M
Pourcentage d'actions détenu par les institutions
75.9%
Oct 31, 2025 | DIRECTOR | 100.00K | $11.25 | $1.13M | BUY | 38.74% | 358.11K | Oct 30 | ||
Aug 22, 2025 | DIRECTOR | 100.00K | $12.56 | $1.26M | BUY | 63.25% | 258.11K | Aug 21 | ||
Aug 06, 2025 | SVP & CHIEF ACCOUNTING OFFICER | -3.48K | $11.39 | -$39.59K | SELL | -5.94% | 55.07K | Aug 05 | ||
May 27, 2025 | DIRECTOR | 30.00K | $12.50 | $375.00K | BUY | 23.42% | 158.11K | May 23 | ||
May 22, 2025 | DIRECTOR | 20.00K | $12.65 | $253.00K | BUY | 18.50% | 128.11K | May 22 | ||
May 09, 2025 | DIRECTOR | 25.00K | $12.00 | $300.00K | BUY | 100.00% | 50.00K | May 07 | ||
Apr 29, 2025 | DIRECTOR | 8.10K | $12.30 | $99.63K | BUY | 30.07% | 35.04K | Apr 29 | ||
Apr 29, 2025 | DIRECTOR | 25.00K | $12.50 | $312.50K | BUY | 60.96% | 66.01K | Apr 28 | ||
Apr 29, 2025 | DIRECTOR | 5.00K | $12.57 | $62.85K | BUY | 16.55% | 35.22K | Apr 28 | ||
Apr 29, 2025 | DIRECTOR | 8.09K | $12.81 | $103.65K | BUY | 4.16% | 202.72K | Apr 28 | ||
Feb 28, 2025 | EVP SALES, CUSTOMER EXCELLENCE | -4.53K | $17.44 | -$79.04K | SELL | -4.97% | 86.61K | Feb 26 - Feb 27 | ||
Feb 28, 2025 | SVP & CHIEF ACCOUNTING OFFICER | -5.94K | $17.44 | -$103.58K | SELL | -13.05% | 39.57K | Feb 26 - Feb 27 | ||
Sep 06, 2024 | SVP & CHIEF ACCOUNTING OFFICER | -3.52K | $25.06 | -$88.34K | SELL | -10.66% | 29.54K | Sep 05 | ||
Aug 01, 2024 | EVP, AMEA | -10.10K | $27.01 | -$272.80K | SELL | -12.02% | 73.93K | Jul 30 - Jul 31 | ||
Mar 12, 2024 | SVP & CHIEF ACCOUNTING OFFICER | -3.69K | $25.63 | -$94.45K | SELL | -9.67% | 34.41K | Mar 08 | ||
Mar 01, 2024 | EVP SALES, CUSTOMER EXCELLENCE | -4.91K | $24.52 | -$120.39K | SELL | -4.85% | 96.23K | Feb 29 | ||
Mar 01, 2024 | EVP, AMEA | -13.07K | $24.53 | -$320.71K | SELL | -13.48% | 83.89K | Feb 29 | ||
Feb 27, 2024 | EVP SALES, CUSTOMER EXCELLENCE | 14.33K | $24.49 | -$151.91K | GRANT | 16.51% | 101.14K | Feb 23 - Feb 27 | ||
Sep 07, 2023 | SVP & CHIEF ACCOUNTING OFFICER | -7.58K | $20.64 | -$156.39K | SELL | -21.19% | 28.19K | Sep 07 | ||
Aug 28, 2023 | EVP, AMERICAS AND EUROPE | -25.00K | $21.47 | -$536.75K | SELL | -13.46% | 160.74K | Aug 25 | ||
Apr 13, 2023 | EVP, AMEA | -1.50K | $21.18 | -$31.73K | SELL | -1.50% | 98.65K | Apr 11 | ||
Mar 06, 2023 | EVP, BIOPHARMA PRODUCTION | -3.91K | $25.00 | -$97.85K | SELL | -3.48% | 108.72K | Mar 03 | ||
Mar 01, 2023 | EVP, BIOPHARMA PRODUCTION | -3.06K | $25.00 | -$76.47K | SELL | -2.64% | 112.63K | Feb 27 | ||
Mar 01, 2023 | EVP, AMEA | -2.32K | $24.32 | -$56.52K | SELL | -2.26% | 100.72K | Feb 28 | ||
Feb 27, 2023 | EVP, AMEA | 5.18K | $24.32 | -$96.34K | GRANT | 5.29% | 103.04K | Feb 23 - Feb 25 | ||
Feb 22, 2023 | EVP, AMEA | -20.33K | $24.14 | -$490.78K | SELL | -17.30% | 97.16K | Feb 20 - Feb 22 | ||
Feb 02, 2023 | EVP, BIOPHARMA PRODUCTION | 12.18K | $24.40 | -$647.94K | GRANT | 13.50% | 102.39K | Jan 31 - Feb 02 | ||
Nov 17, 2022 | EVP & CFO | 12.50K | $20.71 | $258.85K | BUY | 8.87% | 153.38K | Nov 16 | ||
Nov 17, 2022 | CEO | 15.00K | $20.95 | $314.25K | BUY | 0.93% | 1.62M | Nov 16 | ||
May 23, 2022 | EVP, BIOPHARMA PRODUCTION | -19.60K | $31.27 | -$612.99K | SELL | -16.82% | 96.94K | May 20 | ||
May 23, 2022 | EVP, AMERICAS & EUROPE | -39.00K | $31.61 | -$1.23M | SELL | -23.53% | 126.76K | May 23 | ||
Mar 02, 2022 | EVP, BIOPHARMA PRODUCTION | -2.03K | $34.47 | -$69.87K | SELL | -1.47% | 136.22K | Mar 01 | ||
Feb 25, 2022 | EVP, BIOPHARMA PRODUCTION | 10.01K | $34.43 | -$175.67K | GRANT | 7.80% | 138.25K | Feb 23 - Feb 25 | ||
Jan 05, 2022 | EVP, BIOPHARMA PRODUCTION | -18.07K | $29.51 | -$2.05M | SELL | -12.09% | 131.31K | Jan 02 - Jan 05 | ||
Dec 28, 2021 | EVP, AMEA | 0.00 | $32.42 | -$187.59K | SELL-OPTIONS | 0.00% | 110.50K | Dec 27 | ||
Dec 23, 2021 | EVP, AMEA | 0.00 | $32.22 | -$1.20M | SELL-OPTIONS | 0.00% | 110.50K | Dec 21 - Dec 22 | ||
Dec 10, 2021 | EVP, AMEA | 0.00 | $28.90 | -$307.52K | SELL-OPTIONS | 0.00% | 110.50K | Dec 08 - Dec 09 | ||
Dec 03, 2021 | DIRECTOR | -100.00K | $39.30 | -$3.93M | SELL | -10.21% | 879.35K | Dec 01 | ||
Nov 15, 2021 | EVP, EUROPE | -60.80K | $30.76 | -$3.54M | SELL | -28.24% | 154.50K | Nov 11 - Nov 12 | ||
Nov 02, 2021 | DIRECTOR | -100.00K | $40.31 | -$4.03M | SELL | -9.26% | 979.35K | Nov 01 | ||
Oct 04, 2021 | DIRECTOR | -100.00K | $39.94 | -$3.99M | SELL | -8.48% | 1.08M | Oct 01 | ||
Sep 22, 2021 | PRESIDENT AND CEO | -141.30K | $42.37 | -$5.99M | SELL | -10.07% | 1.26M | Sep 20 | ||
Sep 02, 2021 | DIRECTOR | -100.00K | $39.45 | -$3.95M | SELL | -7.82% | 1.18M | Sep 01 | ||
Aug 27, 2021 | SVP & CHIEF ACCOUNTING OFFICER | -17.38K | $40.08 | -$696.71K | SELL | -55.13% | 14.15K | Aug 26 | ||
Aug 23, 2021 | DIRECTOR | -100.00K | $38.81 | -$3.88M | SELL | -7.25% | 1.28M | Aug 20 | ||
Aug 13, 2021 | DIRECTOR | 300.00 | $36.33 | $10.90K | BUY | 0.05% | 650.32K | Jul 12 | ||
Aug 02, 2021 | EVP, BIOPHARMA PRODUCTION | 0.00 | $30.22 | -$1.14M | SELL-OPTIONS | 0.00% | 149.38K | Jul 30 | ||
Jul 21, 2021 | EVP, STRATEGIC PARTNERS | -6.11K | $37.00 | -$226.14K | SELL | -7.11% | 79.90K | Jul 20 | ||
Jul 13, 2021 | EVP, STRATEGIC PARTNERS | -18.33K | $35.61 | -$652.83K | SELL | -17.57% | 86.01K | Jul 09 | ||
Jun 29, 2021 | EVP, AMEA | -28.10K | $35.73 | -$1.00M | SELL | -20.33% | 110.08K | Jun 28 | ||
Jun 28, 2021 | DIRECTOR | -68.61K | $35.32 | -$2.42M | SELL | -4.74% | 1.38M | Jun 25 | ||
Jun 10, 2021 | PRESIDENT AND CEO | 0.00 | $17.69 | -$14.08M | SELL-OPTIONS | 0.00% | 1.40M | Jun 08 - Jun 10 | ||
May 28, 2021 | DIRECTOR | -228.11K | $31.91 | -$7.28M | SELL | -11.67% | 1.73M | May 26 - May 27 | ||
May 28, 2021 | EVP, IMEA | 0.00 | $27.60 | -$878.00K | SELL-OPTIONS | 0.00% | 139.09K | May 27 | ||
May 27, 2021 | EVP, IMEA | 0.00 | $27.54 | -$129.90K | SELL-OPTIONS | 0.00% | 139.09K | May 26 | ||
May 26, 2021 | DIRECTOR | -337.57K | $31.66 | -$10.69M | SELL | -14.73% | 1.95M | May 24 | ||
May 25, 2021 | EVP, IMEA | 0.00 | $24.71 | -$128.47K | SELL-OPTIONS | 0.00% | 139.09K | May 24 | ||
May 24, 2021 | EVP & CIO | -18.49K | $31.41 | -$580.71K | SELL | -14.03% | 113.30K | May 21 | ||
May 21, 2021 | EVP & GENERAL COUNSEL | -18.49K | $31.12 | -$575.35K | SELL | -17.60% | 86.54K | May 20 | ||
May 21, 2021 | EVP, AMEA | -25.01K | $31.13 | -$778.56K | SELL | -15.33% | 138.17K | May 20 | ||
May 21, 2021 | EVP, BIOPHARMA PRODUCTION | -19.60K | $31.10 | -$609.65K | SELL | -11.60% | 149.38K | May 20 | ||
May 13, 2021 | DIRECTOR | -27.26M | $30.85 | -$840.88M | SELL | -99.66% | 92.66K | May 11 | ||
May 07, 2021 | DIRECTOR | -950.00 | $16.33 | -$13.30K | SELL | -0.00% | 72.62M | May 17 - Sep 25 | ||
May 07, 2021 | 10% OWNER | -950.00 | $16.33 | -$13.30K | SELL | -0.00% | 72.62M | May 17 - Sep 25 | ||
May 07, 2021 | DIRECTOR | -950.00 | $16.33 | -$13.30K | SELL | -0.00% | 72.62M | May 17 - Sep 25 | ||
May 04, 2021 | EVP, IMEA | 0.00 | $27.89 | -$502.69K | SELL-OPTIONS | 0.00% | 155.89K | Apr 30 | ||
Apr 13, 2021 | EVP, IMEA | 0.00 | $16.98 | -$3.08M | SELL-OPTIONS | 0.00% | 155.89K | Apr 12 | ||
Apr 13, 2021 | EVP, EUROPE | -27.07K | $31.80 | -$861.00K | SELL | -11.11% | 216.59K | Apr 12 | ||
Apr 13, 2021 | EVP, STRATEGIC PARTNERS | -2.50K | $32.00 | -$80.16K | SELL | -2.08% | 118.14K | Apr 12 | ||
Apr 13, 2021 | EVP & GENERAL COUNSEL | -2.90K | $28.19 | -$1.09M | SELL | -2.38% | 118.68K | Apr 12 | ||
Mar 10, 2021 | EVP, EUROPE | -10.00K | $28.21 | -$282.10K | SELL | -3.94% | 243.67K | Mar 09 | ||
Mar 03, 2021 | EVP & CIO | -3.04K | $28.71 | -$87.16K | SELL | -2.04% | 145.44K | Mar 02 | ||
Feb 26, 2021 | EVP, BIOPHARMA PRODUCTION | -3.06K | $27.93 | -$85.44K | SELL | -1.74% | 172.38K | Feb 24 | ||
Feb 23, 2021 | EVP, BIOPHARMA PRODUCTION | -3.07K | $23.15 | -$304.61K | SELL | -1.72% | 175.44K | Feb 22 | ||
Feb 08, 2021 | EVP & CIO | -9.47K | $26.48 | -$544.66K | SELL | -6.27% | 141.54K | Feb 05 | ||
Jan 13, 2021 | EVP, STRATEGIC PARTNERS | -2.50K | $30.00 | -$75.15K | SELL | -2.11% | 116.43K | Jan 11 | ||
Jan 13, 2021 | EVP, BIOPHARMA PRODUCTION | 0.00 | $26.63 | -$2.60M | SELL-OPTIONS | 0.00% | 178.51K | Jan 11 | ||
Jan 08, 2021 | EVP, BIOPHARMA PRODUCTION | -11.51K | $27.24 | -$313.51K | SELL | -6.06% | 178.51K | Jan 06 | ||
Jan 06, 2021 | EVP, BIOPHARMA PRODUCTION | -6.56K | $23.16 | -$742.57K | SELL | -3.34% | 190.02K | Jan 02 - Jan 04 | ||
Dec 23, 2020 | — | -10.02K | $27.14 | -$271.94K | SELL | -7.84% | 117.77K | Dec 21 | ||
Dec 15, 2020 | — | -14.29K | $26.68 | -$381.15K | SELL | -55.79% | 11.32K | Dec 11 | ||
Dec 08, 2020 | — | 580.33K | $14.38 | -$12.12M | OPTION EXERCISE | 45.81% | 1.85M | Dec 04 - Dec 07 | ||
Nov 10, 2020 | — | -36.02M | $24.81 | -$893.49M | SELL | -56.26% | 28.00M | Nov 10 |
FAQ
Est-ce que le trading d'initiés est légal ?
Le trading d'initiés est légal tant que les initiés signalent ces transactions à la SEC. Le trading de titres illégal se produit lorsque l'initié enfreint un devoir fiduciaire ou omet de signaler ses transactions.
Quels sont quelques exemples de manipulation de marché ?
Le trading d'initiés, les schémas de gonflement et de vidage, le front running et les opérations de lavage sont tous des exemples de manipulation de marché. Les investisseurs qui suivent les mouvements d'actifs des initiés devraient réfléchir attentivement à la raison pour laquelle ces initiés échangent leurs actions avant de passer à l'action.
Parcourir transactions d'initiés sur toutes les actions.